AI News
Friday, July 3, 2026
Muhammad Zulhusni
Takeda signs US$600M AI drug discovery deal with Insilico
AI-Powered Summary
Generated by callmor.ai's AI to save you time
Summary
Takeda has entered a strategic collaboration with Hong Kong-based Insilico Medicine to use AI in early-stage drug discovery across the Japanese pharmaceutical company’s therapeutic areas.
The companies did not disclose which therapeutic areas or disease targets will be covered under the collabora...
Original Source
This article was originally published by AI News. Read the full original article for complete details, images, and author commentary.
Read Original ArticleWant AI working for your business?
callmor.ai builds AI products that automate your operations 24/7.
Explore AI Products